WeGreened Approval Statistics: Week of August 11, 2025

During the week of August 11 to August 17, 2025, WeGreened received a total of 104 approval notices from the United States Citizenship and Immigration Services (USCIS). The EB-2 National Interest Waiver (NIW) category continued to lead in volume, representing almost 70% of approvals, while the EB-1A (Alien of Extraordinary Ability) category maintained a strong presence among accomplished researchers and professionals.

Approval Distribution by Category and Service Center

Of the 104 approvals, 73 were for NIW, 22 for EB1A, 5 for EB1B (Outstanding Professors or Researchers), and 4 for O1A (Individuals with Extraordinary Ability or Achievement).

The Nebraska Service Center processed 12 EB1A and 32 NIW approvals, while the Texas Service Center handled 10 EB1A and 38 NIW approvals. Additionally, three NIW cases were transferred from NSC to TSC.

EB1A and NIW Credential Analysis

EB1A petitioners demonstrated solid academic productivity, with publications ranging from 2 to 67 articles (median 12) and citations between 119 and 3,944 (median 389). This profile reflects significant scholarly achievement and global influence.

NIW petitioners showed a wider distribution of academic records, from 1 to 329 publications (median 8) and citations between 11 and 16,524 (median 114). This diversity highlights USCIS’s continued openness to applicants with practical, policy-relevant, or industry-driven contributions, even without extremely high citation metrics.

Insights on Petitioner Backgrounds and Fields

EB1A approvals spanned precision cardiology, molecular neuroscience, artificial intelligence, human molecular genetics, and biomedical engineering. Many petitioners were affiliated with universities, research institutes, or medical centers in postdoctoral or senior research roles.

NIW cases covered environmental engineering, renewable energy, public health, mechanical engineering, agricultural sciences, and other applied sciences. Many petitioners were industry engineers, policy researchers, or technical specialists whose work aligns with U.S. economic, environmental, and technological priorities.

Highlighted NIW Case: Approval with the Lowest Citation Record

One NIW petitioner approved this week worked in the field of Infectious Disease Epidemiology and Therapeutics. The petitioner had 3 publications and 11 citations, and their petition was adjudicated at the Nebraska Service Center.

While their citation record was modest, our legal team emphasized the public health significance of their work, particularly its applications to infectious disease treatment strategies and epidemic preparedness. We demonstrated that the petitioner’s expertise directly contributes to U.S. healthcare and biomedical priorities, underscoring the national importance of their contributions.

This case illustrates that USCIS continues to recognize the practical and policy-driven impact of research, even when traditional academic metrics such as citation counts are limited.

Adjudication Trends and Policy Observations

EB1A: USCIS continues to focus on documented international acclaim, sustained scholarly excellence, and leadership in the field.

NIW: Adjudicators maintain flexibility and approve petitions across a wide range of academic and industry backgrounds, provided the petition shows substantial merit and national importance.

This week’s highlighted case reinforces that impact matters more than numbers. Applicants with fewer citations can still succeed if their work advances critical U.S. interests in healthcare, technology, or infrastructure.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.